Becton Dickinson EBITDA 2010-2024 | BDX

Becton Dickinson EBITDA for the quarter ending December 31, 2024 was $1.061B, a 9.32% decline year-over-year.

  • Becton Dickinson 2024 EBITDA was 4.684B, a 0% decline from 2024.
  • Becton Dickinson 2024 EBITDA was 4.684B, a 6.48% increase from 2023.
  • Becton Dickinson 2023 EBITDA was 4.399B, a 0% decline from 2023.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Becton Dickinson EBITDA 2010-2024 | BDX

  • Becton Dickinson 2024 EBITDA was 4.684B, a 0% decline from 2024.
  • Becton Dickinson 2024 EBITDA was 4.684B, a 6.48% increase from 2023.
  • Becton Dickinson 2023 EBITDA was 4.399B, a 0% decline from 2023.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$75.5B
Cardinal Health (CAH)$30.6B
Straumann Holding AG (SAUHY)$23.7B
Labcorp (LH)$20.7B
Cooper (COO)$17.3B
Align Technology (ALGN)$15.1B
West Pharmaceutical Services (WST)$14.6B
Henry Schein (HSIC)$9.7B
Merit Medical Systems (MMSI)$6.2B
DENTSPLY SIRONA (XRAY)$3.8B
Patterson (PDCO)$2.7B
CONMED (CNMD)$1.9B
STAAR Surgical (STAA)$876M
Lifevantage (LFVN)$230M
Pro-Dex (PDEX)$112M